COVID-19 has presented a humanitarian crisis like no other, with nearly two million infected by the virus and tens of thousands of lives lost. Indeed, the speed and depth of disruption due to the pandemic is creating unprecedented challenges for societies and economies across the world. This is especially clear on the frontlines of healthcare delivery. As infections spread around the world, health systems have redirected substantial resources to COVID-19 response efforts.COVID-19 has put the medtech industry at center stage with unparalleled demand for diagnostic tests, personal protective equipment (PPE), ventilators, and other critical medical supplies.
What's next for the MedTech industry? The MedTech industry is responding to the immediate crisis; there is no time to make systematic changes. However, MedTech companies can adopt a new mindset of responsible innovation in your response--blending the need for agility, affordability, and outcomes. But COVID-19 is not just a short-term crisis. It will have long-lasting implications for how people work and how we will treat patients. As we emerge from this crisis, there are actions MedTech companies can take to sustain the ability to responsibly innovate and better serve the healthcare community.
In order to get these MedTech companies closer to various healthcare centers, pharmaceuticals, hospitals, etc across the world, Group Futurista comes up with its next webinar ' Re-thinking MedTech for a COVID-19 world'. We bring together key professionals from this sector who will talk about the various issues arising due to the current pandemic situation and how MedTech solutions can help the healthcare industry resolve this issue expeditiously & with responsible innovative technologies.